Skip to main content

Maetzold Derek J's Form 4 filing

Castle Biosciences Inc (CSTL) · filed Nov 9, 2022

Accession no.
0001447362-22-000176
Filed
Nov 9, 2022
Trade date
Nov 7, 2022
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 21 non-derivative transactions. Open-market sales total $182.3K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Maetzold Derek JCIK 0001239501Director, Officer (Pres. & Chief Exec. Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Nov 7, 2022Common StockSSaleDisposed−2,725$20.03F2−$54,581.75293,497Direct
Nov 7, 2022Common StockSSaleDisposed−1,333$20.03F2−$26,699.99131,370Indirect
Nov 7, 2022Common StockSSaleDisposed−1,244$20.03F2−$24,917.32119,730Indirect
Nov 7, 2022Common StockSSaleDisposed−267$20.03F2−$5,348.0126,707Indirect
Nov 7, 2022Common StockSSaleDisposed−267$20.03F2−$5,348.0126,705Indirect
Nov 7, 2022Common StockSSaleDisposed−267$20.03F2−$5,348.0126,705Indirect
Nov 7, 2022Common StockSSaleDisposed−266$20.03F2−$5,327.9826,701Indirect
Nov 7, 2022Common StockSSaleDisposed−1,065$21.09F9−$22,460.85292,432Direct
Nov 7, 2022Common StockSSaleDisposed−521$21.09F9−$10,987.89130,849Indirect
Nov 7, 2022Common StockSSaleDisposed−486$21.09F9−$10,249.74119,244Indirect
Nov 7, 2022Common StockSSaleDisposed−105$21.09F9−$2,214.4526,602Indirect
Nov 7, 2022Common StockSSaleDisposed−104$21.09F9−$2,193.3626,601Indirect
Nov 7, 2022Common StockSSaleDisposed−104$21.09F9−$2,193.3626,601Indirect
Nov 7, 2022Common StockSSaleDisposed−104$21.09F9−$2,193.3626,597Indirect
Nov 7, 2022Common StockSSaleDisposed−43$22.07−$949.01292,389Direct
Nov 7, 2022Common StockSSaleDisposed−21$22.07−$463.47130,828Indirect
Nov 7, 2022Common StockSSaleDisposed−20$22.07−$441.4119,224Indirect
Nov 7, 2022Common StockSSaleDisposed−4$22.07−$88.2826,598Indirect
Nov 7, 2022Common StockSSaleDisposed−4$22.07−$88.2826,597Indirect
Nov 7, 2022Common StockSSaleDisposed−4$22.07−$88.2826,597Indirect
Nov 7, 2022Common StockSSaleDisposed−4$22.07−$88.2826,593Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

This transaction was executed in multiple trades at prices ranging from $19.61 to $20.58, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 7 transactions in Table I.

F9

This transaction was executed in multiple trades at prices ranging from $20.88 to $21.56, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 7 transactions in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)